Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii
about
In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondiiSynergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosisIn vitro and in vivo effects of doxycycline on Toxoplasma gondiiRemarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondiiSynergistic combination of azithromycin and sulfadiazine for treatment of toxoplasmosis in miceQuinupristin-dalfopristin is active against Toxoplasma gondiiActivity of epiroprim (Ro 11-8958), a dihydrofolate reductase inhibitor, alone and in combination with dapsone against Toxoplasma gondiiIn vitro evaluation of the activities of azithromycin alone and combined with pyrimethamine against Toxoplasma gondiiThe ketolide antibiotics HMR 3647 and HMR 3004 are active against Toxoplasma gondii in vitro and in murine models of infectionThe new macrolides. Azithromycin and clarithromycin.Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis.Localization of azithromycin in Toxoplasma gondii-infected cellsDistribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye.Chemotherapy and immunity in opportunistic parasitic infections in AIDS.Azithromycin: the first azalide antibiotic.In vitro effects of three new 1,2,4-trioxanes (pentatroxane, thiahexatroxane, and hexatroxanone) on Toxoplasma gondii.Human antiprotozoal therapy: past, present, and future.Once-a-week azithromycin in AIDS patients: tolerability, kinetics, and effects on zidovudine disposition.Engineering the rRNA decoding site of eukaryotic cytosolic ribosomes in bacteriaThe pharmacokinetics of azithromycin and their clinical significance.Spectrum of activity of azithromycin.The activity of azithromycin in animal models of infection.Azithromycin versus Sulfadiazine and Pyrimethamine for non-vision-threatening toxoplasmic retinochoroiditis: a pilot study.In vitro activity of azithromycin against clinical isolates of Legionella speciesComparative activity of macrolides against Toxoplasma gondii demonstrating utility of an in vitro microassay.Synergistic activity of azithromycin and gamma interferon in murine toxoplasmosisToxoplasmosis during pregnancy: a case report and review of the literature.Drugs in development for toxoplasmosis: advances, challenges, and current status.New directions for macrolide antibiotics: structural modifications and in vitro activity.Recent developments in the prevention and treatment of congenital toxoplasmosis.Plasma pyrimethamine concentrations during long-term treatment for cerebral toxoplasmosis in patients with AIDSOpportunistic/nosocomial infections. Treatment and developmental therapeutics. Toxoplasmosis.The potential role of azithromycin in the treatment of prophylaxis of toxoplasmosis.Mitochondrial ribosome as the target for the macrolide antibiotic clarithromycin in the helminth Echinococcus multilocularisAzithromycin reduces ocular infection during congenital transmission of toxoplasmosis in the Calomys callosus model.In vitro activity of azithromycin and dirithromycin against axenic Entamoeba histolytica.[Evaluation of the efficacy of azithromycin and pyrimethamine, for treatment of experimental infection of mice with Toxoplasma gondii cystogenic strain].[The evaluation of the efficacy of azithromycin and pyrimethamine used alone or in combination in the treatment of an experimental infection in mice by Toxoplasma gondii]
P2860
Q28321674-9D7B2EC9-2EB9-44B9-B7E8-3825A4330CBDQ28326714-F7AD453E-B86D-4846-8CEC-7E59B63D7F37Q28335472-3B8BB37B-77B2-4D30-8B0D-6AD7B2498C9BQ28335576-41AFB7C7-91E7-42FE-828B-162B8EF270F8Q28343091-A8C006E1-C77C-488F-AB0B-BC368EA78BB0Q28343473-FF43BFA6-2133-43D7-A56D-87A2E0950CEFQ28369142-9B103E43-1C22-403A-82F0-FD88566DF447Q28378355-B241DB0F-CE0D-4947-82B7-AFE067763907Q28379168-B8546105-B1B9-494F-BBE9-0CA5D888F41AQ33607251-BE370C4F-5DBB-4DFF-8FC7-5D79D883CCC7Q33745394-AD27D942-B450-479C-8EDD-F8E17A4E215AQ33755229-852E15B0-684D-46CC-9AE7-F9BA807EAA86Q35123496-4F17C213-E80D-4E53-85F9-A2B42D29CDC5Q35224471-3F2B4D50-A19A-4054-8561-06509BE471CEQ35234822-FBF54EDF-EEF6-4457-8444-7A1AE1B66D2BQ35354962-A40670B7-6EAD-469A-915D-A32B664AE133Q35535171-630F3C86-775A-4C85-90E0-6BA435F67A38Q35836068-7FCF6C63-FA5C-4645-B622-DE305E7BA36CQ36168675-CB569178-7361-412A-8F78-1A1EA1533D74Q36454251-119A25B5-DDE4-4C1C-8DE7-D84C1189E049Q36454256-7CDF66D5-E967-4CCB-A6FF-EB3FD504F0B2Q36454260-60E52647-DA6F-4E73-8802-93D5B6049C7AQ36577019-578EC136-C58D-42C2-BC51-CF057B599FDEQ36752693-4F4096C7-D5D1-4C90-A26C-9A8F64323F7EQ36753766-87E2FE82-2409-4B18-BF4F-E4A30D685C48Q36754621-69FDE90C-01F0-4137-B7AB-8A9224B24B3AQ36824204-42743410-61E1-4426-A623-D6CB12F25F47Q37613765-A1BE2A88-2556-400B-80C8-17743856A56FQ38721368-FA1F414F-7D22-4841-AC7E-90A3D3A9BCFCQ38774985-F98C77B1-9B0E-451B-89C9-A54B28014E0AQ39782411-7AADB269-D3D9-4103-B276-04A1496558ACQ40865388-CFFEDBF6-7993-48E8-993D-3F33E48256F6Q41000192-471AE4BB-09F2-4B52-BFA2-44D77B465261Q42645521-40E29381-4483-4370-BDBE-A7CA7A89BCEBQ43202341-BC630DFB-A383-4187-A528-F2568DBD3DA3Q45187784-D136B901-C2BD-46C4-AB35-F753D355FEF0Q46376378-6DD2F82B-A317-4698-9CAF-65917D9E7870Q54563799-85D57500-C505-4966-BB9F-F077DCAF462E
P2860
Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii
description
1988 nî lūn-bûn
@nan
1988 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii
@ast
Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii
@en
Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii
@nl
type
label
Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii
@ast
Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii
@en
Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii
@nl
prefLabel
Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii
@ast
Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii
@en
Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii
@nl
P2093
P2860
P356
P1476
Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii
@en
P2093
D R Guptill
F G Araujo
J S Remington
P2860
P356
10.1128/AAC.32.5.755
P407
P577
1988-05-01T00:00:00Z